​

PROCEPT BioRobotics (PRCT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PRCT Stock Forecast

PROCEPT BioRobotics (PRCT) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $105.00, with a high of $105.00 and a low of $105.00. This represents a 98.00% increase from the last price of $53.03.

$40 $53 $66 $79 $92 $105 High: $105 Avg: $105 Low: $105 Last Closed Price: $53.03

PRCT Stock Rating

PROCEPT BioRobotics stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (84.62%), 2 Hold (15.38%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 2 11 Strong Sell Sell Hold Buy Strong Buy

PRCT Price Target Upside V Benchmarks

TypeNameUpside
StockPROCEPT BioRobotics98.00%
SectorHealthcare Stocks 35.25%
IndustryMedical Device Stocks21.20%

Price Target Trends

1M3M12M
# Anlaysts--6
Avg Price Target--$88.50
Last Closing Price$53.03$53.03$53.03
Upside/Downside--66.89%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25252--9
Mar, 25252--9
Feb, 25262--10
Jan, 25262--10
Dec, 24262--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Patrick WoodMorgan Stanley$105.00$94.9310.61%98.00%
Oct 29, 2024Richard NewitterTruist Financial$105.00$96.249.10%98.00%
Sep 03, 2024Richard NewitterTruist Financial$95.00$79.0020.25%79.14%
Jul 16, 2024Richard NewitterTruist Financial$79.00$68.9014.66%48.97%
May 06, 2024Matt O'BrienPiper Sandler$75.00$64.3116.62%41.43%
May 02, 2024Richard NewitterTruist Financial$72.00$60.6118.79%35.77%
Sep 02, 2022Nathan TreybeckWells Fargo$49.00$40.3821.35%-7.60%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 02, 2024Morgan StanleyOverweightinitialise
Oct 29, 2024BTIGNeutralNeutralhold
Oct 28, 2024William BlairOutperformOutperformhold
Oct 08, 2024Truist FinancialUnderperformUnderperformhold
Sep 16, 2024Cowen & Co.BuyBuyhold
Jul 02, 2024Cowen & Co.BuyBuyhold
May 06, 2024Cowen & Co.BuyBuyhold
May 06, 2024Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.43$-2.11$-2.24$-1.75----
Avg Forecast$-3.04$-1.88$-2.14$-1.74$-1.30$-0.76$-0.02$0.56
High Forecast$-2.93$-1.81$-2.08$-1.69$-1.04$-0.56$-0.02$0.58
Low Forecast$-3.12$-1.95$-2.23$-1.83$-1.55$-1.05$-0.02$0.54
Surprise %-52.96%12.23%4.67%0.57%----

Revenue Forecast

$0 $130M $260M $390M $520M $650M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$34.47M$75.01M$136.19M$224.50M----
Avg Forecast$33.37M$74.15M$134.44M$223.93M$315.00M$415.28M$516.98M$624.64M
High Forecast$34.07M$76.43M$138.14M$224.04M$318.36M$416.43M$528.59M$641.83M
Low Forecast$32.44M$72.02M$129.50M$223.77M$311.07M$414.13M$505.38M$601.68M
Surprise %3.31%1.16%1.30%0.25%----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-62.38M$-93.58M$-105.90M$-91.41M----
Avg Forecast$-143.66M$-88.84M$-101.72M$-83.22M$-70.45M$-43.55M$-1.10M$26.62M
High Forecast$-138.46M$-85.51M$-98.19M$-79.93M$-49.23M$-26.33M$-1.05M$27.57M
Low Forecast$-147.59M$-92.38M$-105.24M$-86.51M$-73.37M$-49.54M$-1.14M$25.35M
Surprise %-56.57%5.34%4.11%9.85%----

PRCT Forecast FAQ

Is PROCEPT BioRobotics stock a buy?

PROCEPT BioRobotics stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that PROCEPT BioRobotics is a favorable investment for most analysts.

What is PROCEPT BioRobotics's price target?

PROCEPT BioRobotics's price target, set by 13 Wall Street analysts, averages $105 over the next 12 months. The price target range spans from $105 at the low end to $105 at the high end, suggesting a potential 98.00% change from the previous closing price of $53.03.

How does PROCEPT BioRobotics stock forecast compare to its benchmarks?

PROCEPT BioRobotics's stock forecast shows a 98.00% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical device stocks industry (21.20%).

What is the breakdown of analyst ratings for PROCEPT BioRobotics over the past three months?

  • April 2025: 22.22% Strong Buy, 55.56% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 22.22% Strong Buy, 55.56% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is PROCEPT BioRobotics’s EPS forecast?

PROCEPT BioRobotics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.3, marking a -25.71% decrease from the reported $-1.75 in 2024. Estimates for the following years are $-0.76 in 2026, $-0.02 in 2027, and $0.56 in 2028.

What is PROCEPT BioRobotics’s revenue forecast?

PROCEPT BioRobotics's average annual revenue forecast for its fiscal year ending in December 2025 is $315M, reflecting a 40.32% increase from the reported $224.5M in 2024. The forecast for 2026 is $415.28M, followed by $516.98M for 2027, and $624.64M for 2028.

What is PROCEPT BioRobotics’s net income forecast?

PROCEPT BioRobotics's net income forecast for the fiscal year ending in December 2025 stands at $-70.45M, representing a -22.93% decrease from the reported $-91.413M in 2024. Projections indicate $-43.549M in 2026, $-1.096M in 2027, and $26.62M in 2028.